Connaught is an internal program that provides U of T researchers with funding to further their work.
Some funds are specifically designed for young researchers to get their research careers started. Other funds focus on interdisciplinary work and innovation – with a strong emphasis on meeting challenges facing global society.
The Connaught Fund was founded in 1972 when U of T sold the Connaught Medical Research Laboratories for $29 million. The lab had been established in 1914 to produce diphtheria antitoxin. After the 1921 discovery of insulin by U of T researchers Frederick Banting and Charles Best, the lab expanded and began producing insulin as well as other vaccine and antitoxins.
Connaught is the largest internal university research funding program in Canada. Since 1972, it has awarded approximately $150 million to U of T scholars. The original $29 million was endowed. Today, Connaught is worth over $112 million.